Ablepharon macrostomia syndrome: A distinct genetic entity clinically related to the group of FRAS-FREM complex disorders

Denny Schanze, Magdalena Harakalova, Cathy A Stevens, Francesco Brancati, Bruno Dallapiccola, Peter Farndon, Victor E F Ferraz, Donna M McDonald-McGinn, Elaine H Zackai, Michael Wright, Stef van Lieshout, Maartje J Vogel, Mieke M van Haelst, Martin Zenker

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Ablepharon macrostomia syndrome (AMS; OMIM 200110) is an extremely rare congenital malformation syndrome. It overlaps clinically with Fraser syndrome (FS; OMIM 219000), which is known to be caused by mutations in either FRAS1, FREM2, or GRIP1, encoding components of a protein complex that plays a role in epidermal-dermal interactions during morphogenetic processes. We explored the hypothesis that AMS might be either allelic to FS or caused by mutations in other genes encoding known FRAS1 interacting partners. No mutation in either of these genes was found in a cohort of 11 patients with AMS from 10 unrelated families. These findings demonstrate that AMS is genetically distinct from FS. It is proposed that it constitutes a separate entity within the group of FRAS-FREM complex disorders.

Original languageEnglish
Pages (from-to)3012-7
Number of pages6
JournalAmerican Journal of Medical Genetics Part A
Volume161A
Issue number12
DOIs
Publication statusPublished - Dec 2013

Cite this

Schanze, D., Harakalova, M., Stevens, C. A., Brancati, F., Dallapiccola, B., Farndon, P., ... Zenker, M. (2013). Ablepharon macrostomia syndrome: A distinct genetic entity clinically related to the group of FRAS-FREM complex disorders. American Journal of Medical Genetics Part A, 161A(12), 3012-7. https://doi.org/10.1002/ajmg.a.36119